Entellus Medical, Inc. Common Stock
ENTL
ENTL was delisted on the 27th of February, 2018.
69 hedge funds and large institutions have $234M invested in Entellus Medical, Inc. Common Stock in 2017 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 33 increasing their positions, 14 reducing their positions, and 8 closing their positions.
138% more first-time investments, than exits
New positions opened: 19 | Existing positions closed: 8
136% more repeat investments, than reductions
Existing positions increased: 33 | Existing positions reduced: 14
10% more funds holding
Funds holding: 63 → 69 (+6)
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
10% less capital invested
Capital invested by funds: $259M → $234M (-$25.5M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DGI
Discovery Group I
Chicago,
Illinois
|
+$19.1M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$13.8M |
| 3 |
FCM
Frontier Capital Management
Boston,
Massachusetts
|
+$7.52M |
| 4 |
BlackRock
New York
|
+$6.9M |
| 5 |
ACM
Archon Capital Management
Seattle,
Washington
|
+$5.73M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EWM
Essex Woodlands Management
The Woodlands,
Texas
|
-$9.34M |
| 2 |
SHI
SV Health Investors
Boston,
Massachusetts
|
-$8.56M |
| 3 |
Wells Fargo
San Francisco,
California
|
-$5.99M |
| 4 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
-$2.48M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$2.19M |
ENTL Hedge Fund Activity: Q1 2017 in Review
69 of the 4,034 institutional investors tracked by Wall St. Rank reported a position in Entellus Medical, Inc. Common Stock (ENTL) for Q1 2017, worth a combined $234M — down 9.9% from $259M a quarter earlier.
Buyers outnumbered sellers: 19 funds opened new ENTL positions and 8 closed out — a net gain of 11 holders — while 33 added to existing stakes and 14 trimmed.
The largest buyer was Discovery Group I, adding an estimated $19.1M. The largest seller was Essex Woodlands Management, cutting an estimated $9.34M.
- 69 institutional investors held Entellus Medical, Inc. Common Stock (ENTL) as of Q1 2017, up from 63 in Q4 2016.
- Funds reported $234M of Entellus Medical, Inc. Common Stock stock for Q1 2017, down 9.9% quarter-over-quarter.
- 19 funds opened new Entellus Medical, Inc. Common Stock positions in Q1 2017 and 8 closed out, a net change of +11 holders.
- The largest Entellus Medical, Inc. Common Stock buyer in Q1 2017 was Discovery Group I, an estimated $19.1M added.
- The largest Entellus Medical, Inc. Common Stock seller in Q1 2017 was Essex Woodlands Management, an estimated $9.34M sold.
Based on aggregated 13F filings for Q1 2017.